|
08.30
|
Opening of the virtual conference room
|
|
09.00
|
Welcome, introduction & logistical aspects
Dr. Thomas Heinz, Novartis
|
Session 1
Chair: Dr. René Wyler, Novartis Pharma AG
|
|
09.15
|
Dr. Stefanie Flohr & Dr. Philipp Lustenberger, Novartis
«LNP023 / iptacopan: Discovery and Synthesis Development of a First-in-Class, Oral Factor B Inhibitor for the Treatment of Rare Renal and Hematological Diseases»
|
|
09.45
|
Dr. Sarah Sulzer, Syngenta
«Sustainable Crop Protection Solutions»
|
|
10.15
|
2x Short Lectures
Dr. Marc Liniger, Givaudan
«A Sea Breeze of Novel Fragrant Indanyl Aldehydes»
Dr. Vijay Pattabiraman, Bright Peak Therapeutics
«Designer Protein Therapeutics»
|
|
10.45
|
Break
|
Session 2
Chair: Dr. Heyley Binch, F. Hoffmann-La Roche Ltd
|
|
11.00
|
Dr. Jonathan Medlock, DSM
«New Routes to Old Molecules: Improving the Synthesis of some Water Soluble Vitamins»
|
|
11.30
|
2x Short Lectures
Dr. Steffen Eller, Chemspeed
«Gamification of Research & Development»
Dr. Florian Bächle, Solvias
«The Power of Applied Chemocatalysis»
|
|
12.00
|
Lunch Break,Virtual Poster Session
|
|
13.50
|
Welcome, Introduction & logistical aspects
|
Session 3
Chair: Prof. Olivier Baudoin, University of Basel
|
|
14.00
|
Dr. Cornelia Zumbrunn, Idorsia
«Antibacterial drug discovery today: more than “just” scientific challenges.
The discovery of topoisomerase inhibitor ACT-452051»
|
|
14.30
|
3x short lectures
Dr. Francesco Santoro, Firmenich
«Process Research and Industrialization of a powerful coconut-scented fragrance ingredient using safe and economical Hydroboration and Homogeneous Catalytic Dehydrogenation»
Dr. Thierry Jousseaume, Johnson&Johnson
«Asymmetric Synthesis of Esketamine»
Dr. Radka Snajdrova, Novartis
«Discovery and applications of enzymes in the synthesis of drugs and drug candidates»
|
|
15.15
|
Break
|
Session 4
Chair: Dr. Jérôme Cassayre, Syngenta Crop Protection AG
|
|
15.30
|
Dr. Georg Wuitschik, Roche
«ChemPager and how to make 37kg of RG7834»
|
|
16.00
|
Dr. Reto Naef, Topadur
«NO to aging and cancer»
|
|
16.30
|
SusChem Switzerland: Organization, Strategy and Focus Topics
Dr. Maud Reiter, Firmenich and Dr. Edouard Godineau, Syngenta
|
|
16.45
|
Ceremony Best Presentation Award
Dr. Fabrice Gallou, Novartis Pharma AG
Dr. Richard Smith, Helvetica
|
|
17.00
|
Closing remark
Dr. Alain De Mesmaeker, President of the Swiss Chemical Society
|
